A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony Chalmers
Beatson West of Scotland Cancer Centre
Principal Investigator - Brandon Imber
Memorial Sloan Kettering Cancer Center
Principal Investigator - Deborah Forst
Massachusetts General Hospital
Principal Investigator - Jan Drappatz
UPMC Hospital Radiation Oncology
Principal Investigator - Kazuhiko Mishima
Saitama Medical University International Medical Center
Principal Investigator - Louise Murray
University of Leeds
Principal Investigator - Mariza Daras
VCU Massey Cancer Center
Principal Investigator - Rajesh Jena
Cambridge University Hospitals NHS Foundation Trust
Principal Investigator - Yoshiki Arakawa
Kyoto University Hospital
Principal Investigator - Yoshitaka Narita
National Cancer Center Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Chūōku, Japan
Completed - Research Site
Hidaka-shi, Japan
Active, not recruiting - Research Site
Kyoto, Japan
Active, not recruiting
- Research Site
Cambridge, United Kingdom
Active, not recruiting - Research Site
Glasgow, United Kingdom
Completed - Research Site
Leeds, United Kingdom
Recruiting - Research Site
London, United Kingdom
Withdrawn
- Research Site
Boston, Massachusetts, United States
Recruiting - Research Site
Boston, Massachusetts, United States
Recruiting - Research Site
New York, New York, United States
Recruiting - Research Site
Pittsburgh, Pennsylvania, United States
Recruiting - Research Site
Richmond, Virginia, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Apr 2018
- Primary completion
- 16 Sept 2026
- Completion
- 16 Sept 2026
- Last update posted
- 22 Dec 2025
- Registered enrollment
- 180
- Registry id
- NCT03423628
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.